Triest Filip Jj, Singh Sally J, Vanfleteren Lowie Egw
Department of Research and Education, Centre of Expertise for Chronic Organ Failure (CIRO+), Horn, the Netherlands Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands
Centre for Exercise and Rehabilitation Science, University Hospitals of Leicester NHS Trust, Leicester, UK.
Chron Respir Dis. 2016 Aug;13(3):286-94. doi: 10.1177/1479972316642367. Epub 2016 Apr 14.
Patients with chronic obstructive pulmonary disease (COPD) who participate in pulmonary rehabilitation (PR) often have concomitant cardiovascular disease (CVD), which is a frequently undiagnosed and undertreated comorbidity. CVD contributes to the burden of the disease and is associated with an increased risk for hospitalizations and mortality. Optimizing the diagnosis and management of cardiovascular risk and disease should be considered as part of the holistic approach of PR. In addition, we need to consider similarities and differences in cardiac and PR programs, in order to improve personalized care in patients with both diseases. The current review addresses the burden of CVD in COPD patients who participate in PR, how CVD and its risk factors affect PR and should be managed during PR, and extends on what we can learn of the organization of cardiac rehabilitation programs.
参与肺康复（PR）的慢性阻塞性肺疾病（COPD）患者常伴有心血管疾病（CVD），这是一种经常未被诊断和治疗不足的合并症。心血管疾病加重了疾病负担，并与住院和死亡风险增加相关。优化心血管风险和疾病的诊断与管理应被视为肺康复整体方法的一部分。此外，我们需要考虑心脏康复和肺康复项目的异同，以便改善这两种疾病患者的个性化护理。本综述探讨了参与肺康复的COPD患者的心血管疾病负担、心血管疾病及其危险因素如何影响肺康复以及在肺康复期间应如何管理，还扩展了我们对心脏康复项目组织的认识。
